What is the address of Docteur Sophie Allepaerts, gériatrie?

The registered office of Docteur Sophie Allepaerts, gériatrie is located at Rue Troleu(LVG) 50, 4141 Sprimont.

Is Docteur Sophie Allepaerts, gériatrie still active?

Yes. According to the CBE (28 September 2026) Docteur Sophie Allepaerts, gériatrie is active, legal situation “Normale toestand”, started on 2 March 2022.

Is Docteur Sophie Allepaerts, gériatrie registered on Peppol?

Yes, Docteur Sophie Allepaerts, gériatrie is registered on the Peppol network with ID 0208:0782812467.

What is the enterprise number of Docteur Sophie Allepaerts, gériatrie?

The enterprise number of Docteur Sophie Allepaerts, gériatrie is BE0782812467.

When was Docteur Sophie Allepaerts, gériatrie founded?

Docteur Sophie Allepaerts, gériatrie was founded on 2 March 2022.

Who are the directors of Docteur Sophie Allepaerts, gériatrie?

According to the 2025 annual accounts, the directors of Docteur Sophie Allepaerts, gériatrie are: Sophie Allepaerts.

Is Docteur Sophie Allepaerts, gériatrie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 March 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Docteur Sophie Allepaerts, gériatrie make in 2025?

Docteur Sophie Allepaerts, gériatrie posted a profit after taxes of € 105,548 in financial year 2025.

What is the revenue of Docteur Sophie Allepaerts, gériatrie?

As a small company, Docteur Sophie Allepaerts, gériatrie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 146,407.

Docteur Sophie Allepaerts, gériatrie (Private Limited)

Dossier Docteur Sophie Allepaerts, gériatrie, printed on 28 September 2026 from databakkes.be/en/0782812467/docteur-sophie-allepaerts-geriatrie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Docteur Sophie Allepaerts, gériatrie from Sprimont, company number BE0782812467, closed financial year 2025 with a result of € 105,548 after tax. For that financial year Docteur Sophie Allepaerts, gériatrie recorded a gross margin of € 146,407 and equity of € 3,000. Compared with financial year 2024, the result moved from € 110,334 to € 105,548. The company is profitable. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 25, 2026.

What it is worth Shrank hard

€ 3,000

▼ 99% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 105,548

▼ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 288,762

▲ 27% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 411,921 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 18,316

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 780

▼ 59% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 144,272 Gross margin 2022: € 144,272 First fiscal year in the series	€ 146,397 Gross margin 2023: € 146,397 ▲ 1% vs 2022 (€ 144,272) Favourable step	€ 150,858 Gross margin 2024: € 150,858 ▲ 3% vs 2023 (€ 146,397) Favourable step	€ 146,407 Gross margin 2025: € 146,407 ▼ 3% vs 2024 (€ 150,858) Unfavourable step	▼ 3%
Profit after taxes	€ 115,722 Profit after taxes 2022: € 115,722 First fiscal year in the series	€ 108,117 Profit after taxes 2023: € 108,117 ▼ 7% vs 2022 (€ 115,722) Unfavourable step	€ 110,334 Profit after taxes 2024: € 110,334 ▲ 2% vs 2023 (€ 108,117) Favourable step	€ 105,548 Profit after taxes 2025: € 105,548 ▼ 4% vs 2024 (€ 110,334) Unfavourable step	▼ 4%
Equity	€ 91,722 Equity 2022: € 91,722 First fiscal year in the series	€ 199,039 Equity 2023: € 199,039 ▲ 117% vs 2022 (€ 91,722) Favourable step	€ 309,373 Equity 2024: € 309,373 ▲ 55% vs 2023 (€ 199,039) Favourable step	€ 3,000 Equity 2025: € 3,000 ▼ 99% vs 2024 (€ 309,373) Unfavourable step	▼ 99%
Total debts	€ 56,403 Total debts 2022: € 56,403 First fiscal year in the series	€ 34,805 Total debts 2023: € 34,805 ▼ 38% vs 2022 (€ 56,403) Favourable step	€ 4,367 Total debts 2024: € 4,367 ▼ 87% vs 2023 (€ 34,805) Favourable step	€ 333,444 Total debts 2025: € 333,444 ▲ € 329,077 vs 2024 (€ 4,367) Unfavourable step	▲ € 329,077
Cash	€ 46,964 Cash 2022: € 46,964 First fiscal year in the series	€ 121,066 Cash 2023: € 121,066 ▲ 158% vs 2022 (€ 46,964) Favourable step	€ 227,297 Cash 2024: € 227,297 ▲ 88% vs 2023 (€ 121,066) Favourable step	€ 288,762 Cash 2025: € 288,762 ▲ 27% vs 2024 (€ 227,297) Favourable step	▲ 27%
Retained profit	€ 88,722 Retained profit 2022: € 88,722 First fiscal year in the series	€ 196,039 Retained profit 2023: € 196,039 ▲ 121% vs 2022 (€ 88,722) Favourable step	€ 306,373 Retained profit 2024: € 306,373 ▲ 56% vs 2023 (€ 196,039) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 306,373) Unfavourable step	▼ 100%
Dividend	€ 27,000 Dividend 2022: € 27,000 First fiscal year in the series	€ 800 Dividend 2023: € 800 ▼ 97% vs 2022 (€ 27,000) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 800) Unchanged	€ 411,921 Dividend 2025: € 411,921 Unchanged (€ 0) Unchanged
Balance sheet total	€ 148,125 Balance sheet total 2022: € 148,125 First fiscal year in the series	€ 233,844 Balance sheet total 2023: € 233,844 ▲ 58% vs 2022 (€ 148,125) Unchanged	€ 313,740 Balance sheet total 2024: € 313,740 ▲ 34% vs 2023 (€ 233,844) Unchanged	€ 336,444 Balance sheet total 2025: € 336,444 ▲ 7% vs 2024 (€ 313,740) Unchanged	▲ 7%

Key figures of Docteur Sophie Allepaerts, gériatrie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Docteur Sophie Allepaerts, gériatrie?

What happened at Docteur Sophie Allepaerts, gériatrie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 25, 2026 New annual accounts for financial year 2025: profit of € 105,548 (▼ 4% vs 2024). filed late Source: NBB ↗
Apr 11, 2022 New establishment in Sprimont. KBO
2022 Sophie Allepaerts became a director. NBB
Mar 2, 2022 Start of the company according to the CBE. KBO

In short

From € 115,722 profit in 2022 to € 105,548 profit in 2025.

Paid € 113,145 in corporate taxes since 2022.

Best year ever: 2022, with € 115,722 profit.

Paid out € 439,721 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Docteur Sophie Allepaerts, gériatrie? We notify you, reason included.

Follow Docteur Sophie Allepaerts, gériatrie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Sophie Allepaerts

Docteur Sophie Allepaerts, gériatrie

Behind Docteur Sophie Allepaerts, gériatrie is Sophie Allepaerts.

See the full network in the app

Directors

According to the 2025 annual accounts

Sophie Allepaerts

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Troleu(LVG) 50

4141 Sprimont

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

CardioPlan

€ 298,664 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0782.812.467
VAT number: BE 0782.812.467
Registered office: Rue Troleu(LVG) 50, 4141 Sprimont
Names & denominations: Docteur Sophie Allepaerts, gériatrie · GERISOL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 2 March 2022
Peppol: Active · Active since 14 Sept 2026
Contact: [email protected] +32478548263

View on CBE Public ↗ Annual accounts (NBB) ↗